Journal of Heart and Lung Transplantation

Article	Citations
Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation	344
The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-eighth adult lung transplantation report — 2021; Focus on recipient charact	245
A 5-year single-center early experience of heart transplantation from donation after circulatory-determined death donors	161
The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: 37th adult heart transplantation report—2020; focus on deceased donor characterist	154
The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-eighth adult heart transplantation report — 2021; Focus on recipient charac	146
The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients	127
Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registry	116
BNT162b2 vaccination in heart transplant recipients: Clinical experience and antibody response	112
Updated definitions of adverse events for trials and registries of mechanical circulatory support: A consensus statement of the mechanical circulatory support academic research consortium	111
Early US experience with cardiac donation after circulatory death (DCD) using normothermic regional perfusion	111
Immunogenicity of BNT162b2 mRNA COVID-19 vaccine and SARS-CoV-2 infection in lung transplant recipients	103
Third dose of the BNT162b2 vaccine in heart transplant recipients: Immunogenicity and clinical experience	79
MitraClip in secondary mitral regurgitation as a bridge to heart transplantation: 1-year outcomes from the International MitraBridge Registry	75
Gut microbiota, endotoxemia, inflammation, and oxidative stress in patients with heart failure, left ventricular assist device, and transplant	68
The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: 37th adult lung transplantation report — 2020; focus on deceased donor characteris	66
Left ventricular assist systems and infection-related outcomes: A comprehensive analysis of the MOMENTUM 3 trial	61
Pig-to-non-human primate heart transplantation: The final step toward clinical xenotransplantation?	60
Circulating extracellular vesicles as non-invasive biomarker of rejection in heart transplant	59
Mortality in patients with cardiogenic shock supported with VA ECMO: A systematic review and meta-analysis evaluating the impact of etiology on 29,289 patients	56
Artificial intelligence for early prediction of pulmonary hypertension using electrocardiography	56
The 2023 International Society for Heart and Lung Transplantation Guidelines for Mechanical Circulatory Support: A 10- Year Update	54
SARS-CoV-2 messenger RNA vaccine antibody response and reactogenicity in heart and lung transplant recipients	52
Heart transplantation following donation after circulatory death: Expanding the donor pool	50
Risk assessment of chronic lung allograft dysfunction phenotypes: Validation and proposed refinement of the 2019 International Society for Heart and Lung Transplantation classification system	49
The impact of frailty on mortality after heart transplantation	49

International Society for Heart and Lung Transplantation consensus statement for the standardization of bronchoalveolar lavage in lung transplantation	49
COVID-19 vaccination in our transplant recipients: The time is now	47
Update to an early investigation of outcomes with the new 2018 donor heart allocation system in the United States	44
Berlin Heart EXCOR and ACTION post-approval surveillance study report	44
The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-ninth adult lung transplantation report—2022; focus on lung transplant reci	43
Donor-derived cell-free DNA accurately detects acute rejection in lung transplant patients, a multicenter cohort study	43
Increased early acute cellular rejection events in hepatitis C-positive heart transplantation	40
Systemic ventricular assist device support in Fontan patients: A report by ACTION	40
ISHLT consensus statement for the selection and management of pediatric and congenital heart disease patients on ventricular assist devices Endorsed by the American Heart Association	40
Evaluation and management of patients with chronic thromboembolic pulmonary hypertension - consensus statement from the ISHLT	38
Donor heart selection: Evidence-based guidelines for providers	37
The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Twenty-fourth pediatric heart transplantation report — 2021; focus on recipient ch	37
Coronavirus disease 2019 in heart transplant recipients: Risk factors, immunosuppression, and outcomes	36
Improved survival after heart transplantation in patients bridged with extracorporeal membrane oxygenation in the new allocation system	36
Right ventricular function and cardiopulmonary performance among patients with heart failure supported by durable mechanical circulatory support devices	36
The results of a single-center experience with HeartMate 3 in a biventricular configuration	35
First in man evaluation of a novel circulatory support device: Early experience with the Impella 5.5 after CE mark approval in Germany	35
Oral anticoagulants (NOAC and VKA) in chronic thromboembolic pulmonary hypertension	34
Mitochondrial transplantation for myocardial protection in ex-situ‒perfused hearts donated after circulatory death	34
Selexipag for the treatment of children with pulmonary arterial hypertension: First multicenter experience in drug safety and efficacy	33
Interest of TAPSE/sPAP ratio for noninvasive pulmonary arterial hypertension risk assessment	32
The International thoracic organ transplant registry of the international society for heart and lung transplantation: Thirty-ninth adult heart transplantation report—2022; focus on transplant for rest	32
Is it too early to investigate survival outcomes of the new US heart allocation system?	32
COVID-19 in a pediatric heart transplant recipient: Emergence of donor-specific antibodies	31
Outcomes in the 2018 UNOS donor heart allocation system: A perspective on disparate analyses	31
Pregnancy in pulmonary arterial hypertension: Midterm outcomes of mothers and offspring	31
Cell death and ischemia-reperfusion injury in lung transplantation	31
Cell-free DNA beyond a biomarker for rejection: Biological trigger of tissue injury and potential therapeutics	31
Use of donor-derived-cell-free DNA as a marker of early allograft injury in primary graft dysfunction (PGD) to predict the risk of chronic lung allograft dysfunction (CLAD)	31
Ethical considerations regarding heart and lung transplantation and mechanical circulatory support during the COVID-19 pandemic: an ISHLT COVID-19 Task Force statement	30
Expanding Heart Transplants from Donors After Circulatory Death (DCD) - Results of the First Randomized Controlled Trial Using the Organ Care System (OCS™) Heart - (OCS DCD Heart Trial)	29
The International Society for Heart and Lung Transplantation/Heart Failure Society of America Guideline on Acute Mechanical Circulatory Support	29
Clinical myocardial recovery in advanced heart failure with long term left ventricular assist device support	29
Less invasive surgical implant strategy and right heart failure after LVAD implantation	29
Hemodynamics and risk assessment 2 years after the initiation of upfront ambrisentan‒tadalafil in pulmonary arterial hypertension	28
Incidence and impact of primary graft dysfunction in adult heart transplant recipients: A systematic review and meta-analysis	27
Risk stratification and response to therapy in patients with pulmonary arterial hypertension and comorbidities: A COMPERA analysis	27
The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: 23rd pediatric heart transplantation report—2020; focus on deceased donor characte	27
Prediction of donor related lung injury in clinical lung transplantation using a validated ex vivo lung perfusion inflammation score	27
Clinical outcomes and healthcare expenditures in the real world with left ventricular assist devices – The CLEAR-LVAD study	26
Long-term outcomes after intraoperative extracorporeal membrane oxygenation during lung transplantation	26
A case series of novel coronavirus infection in heart transplantation from 2 centers in the pandemic area in the North of Italy	26
Ex situ heart perfusion: The past, the present, and the future	26
COVID-19 vaccination immune paresis in heart and lung transplantation	25
Comparison of combined heart‒liver vs heart-only transplantation in pediatric and young adult Fontan recipients	25
Challenges in heart transplantation during COVID-19: A single-center experience	25
Percutaneous versus surgical cannulation for femoro-femoral VA-ECMO in patients with cardiogenic shock: Results from the Extracorporeal Life Support Organization Registry	25
Circulating exosomes with lung self-antigens as a biomarker for chronic lung allograft dysfunction: A retrospective analysis	25
Severe pulmonary hypertension associated with chronic obstructive pulmonary disease: A prospective French multicenter cohort	24
Many heart transplant biopsies currently diagnosed as no rejection have mild molecular antibody-mediated rejection-related changes	24

Donor-derived cell-free DNA as a composite marker of acute lung allograft dysfunction in clinical care	24
International consensus recommendations for anesthetic and intensive care management of lung transplantation. An EACTAIC, SCA, ISHLT, ESOT, ESTS, and AST approved document	24
The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Twenty-fourth pediatric lung transplantation report — 2021; Focus on recipient cha	24
Risk factors for mortality in lung transplant recipients aged ≥65 years: A retrospective cohort study of 5,815 patients in the scientific registry of transplant recipients	24
Lung transplantation for idiopathic pulmonary fibrosis enriches for individuals with telomere-mediated disease	23
Clinical utility of donor-derived cell-free DNA testing in cardiac transplantation	23
Arterial oxygen and carbon dioxide tension and acute brain injury in extracorporeal cardiopulmonary resuscitation patients: Analysis of the extracorporeal life support organization registry	23
Bridging the survival gap in cystic fibrosis: An investigation of lung transplant outcomes in Canada and the United States	23
Serial right heart catheter assessment between balloon pulmonary angioplasty sessions identify procedural factors that influence response to treatment	23
Gender and racial disparities in lung transplantation in the United States	22
Epicardial transplantation of atrial appendage micrograft patch salvages myocardium after infarction	22
Circulating miR-181a-5p as a new biomarker for acute cellular rejection in heart transplantation	22
A novel donor-derived cell-free DNA assay for the detection of acute rejection in heart transplantation	22
Transplanting thoracic COVID-19 positive donors: An institutional protocol and report of the first 14 cases	22
Long-term survival on LVAD support: Device complications and end-organ dysfunction limit long-term success	22
Donor-specific antibody characteristics, including persistence and complement-binding capacity, increase risk for chronic lung allograft dysfunction	22
CFTR modulator use in post lung transplant recipients	21
A novel method of donor‒recipient size matching in pediatric heart transplantation: A total cardiac volume‒predictive model	21
Elevated pulmonary arterial elastance and right ventricular uncoupling are associated with greater mortality in advanced heart failure	21
Impact of carfilzomib-based desensitization on heart transplantation of sensitized candidates	21
Collapsing glomerulopathy associated with COVID-19 infection in a heart transplant recipient	21
Clinical impact of concomitant tricuspid valve procedures during left ventricular assist device implantation	21
Therapeutic efficacy of large aligned cardiac tissue derived from induced pluripotent stem cell in a porcine ischemic cardiomyopathy model	21
Riociguat and balloon pulmonary angioplasty improve prognosis in patients with inoperable chronic thromboembolic pulmonary Hypertension	21
Impact of lung morphology on clinical outcomes with riociguat in patients with pulmonary hypertension and idiopathic interstitial pneumonia: A post hoc subgroup analysis of the RISE-IIP study	20
Azithromycin prophylaxis after lung transplantation is associated with improved overall survival	20
Percutaneous RVAD with the Protek Duo for severe right ventricular primary graft dysfunction after heart transplant	20
Risk factors of invasive fungal infections in lung transplant recipients: A systematic review and meta-analysis	20
Recipient and surgical factors trigger severe primary graft dysfunction after heart transplant	20
Pig heart and lung xenotransplantation: Present status	20
Preservation by cold storage vs ex vivo normothermic perfusion of marginal donor hearts: clinical, histopathologic, and ultrastructural features	20
Bronchoalveolar bile acid and inflammatory markers to identify high-risk lung transplant recipients with reflux and microaspiration	20
Ex vivo treatment of cytomegalovirus in human donor lungs using a novel chemokine-based immunotoxin	19
ISHLT consensus statement: Perioperative management of patients with pulmonary hypertension and right heart failure undergoing surgery	19
Clinical characteristics, management practices, and outcomes among lung transplant patients with COVID-19	19
Aspiration of conjugated bile acids predicts adverse lung transplant outcomes and correlates with airway lipid and cytokine dysregulation	19
Reproductive health after thoracic transplantation: An ISHLT expert consensus statement	19
Glycation of ryanodine receptor in circulating lymphocytes predicts the response to cardiac resynchronization therapy	19
The effect of COVID-19 on transplant function and development of CLAD in lung transplant patients: A multicenter experience	19
Contemporary trends in PGD incidence, outcomes, and therapies	18
Use of metabolomics to identify strategies to improve and prolong ex vivo lung perfusion for lung transplants	18
The International thoracic organ transplant registry of the international society for heart and lung transplantation: Twenty-fifth pediatric heart transplantation report—2022; focus on infant heart tr	18
Innate allorecognition in transplantation	18
Molecular T-cell‒mediated rejection in transbronchial and mucosal lung transplant biopsies is associated with future risk of graft loss	18
A current era analysis of ABO incompatible listing practice and impact on outcomes in young children requiring heart transplantation	18
ISHLT position paper on thoracic organ transplantation in controlled donation after circulatory determination of death (cDCD)	18
Thoracoabdominal normothermic regional perfusion in donation after circulatory death does not restore brain blood flow	18
Risk assessment in patients with pulmonary arterial hypertension in the era of COVID 19 pandemic and the telehealth revolution: State of the art review	18
Venous or arterial thromboses after venoarterial extracorporeal membrane oxygenation support: Frequency and risk factors	18
Effects of GLP-1 receptor agonists and SGLT-2 inhibitors in heart transplant patients with type 2 diabetes: Initial report from a cardiometabolic center of excellence	18
The lung microbiome in lung transplantation	18
Incidence and long-term outcome of heart transplantation patients who develop postoperative renal failure requiring dialysis	17
MicroRNA-206 antagomiR‒enriched extracellular vesicles attenuate lung ischemia‒reperfusion injury through CXCL1 regulation in alveolar epithelial cells	17
Quantifying the impact from stroke during support with continuous flow ventricular assist devices: An STS INTERMACS analysis	17
Exercise right ventricular ejection fraction predicts right ventricular contractile reserve	17
Cytomegalovirus prevention in thoracic organ transplantation: A single-center evaluation of letermovir prophylaxis	17
The impaired diaphragmatic function after bilateral lung transplantation: A multifactorial longitudinal study	17
The influence of mechanical Circulatory support on post-transplant outcomes in pediatric patients: A multicenter study from the International Society for Heart and Lung Transplantation (ISHLT) Registr	17
Risk assessment in severe pulmonary hypertension due to interstitial lung disease	17
A CLUE for better assessment of donor lungs: Novel technique in clinical ex vivo lung perfusion	16
A challenge to equity in transplantation: Increased center-level variation in short-term mechanical circulatory support use in the context of the updated U.S. heart transplant allocation policy	16
Successful salvage therapy for fungal bronchial anastomotic infection after –lung transplantation with an inhaled triazole anti-fungal PC945	16
Surveillance for cardiac allograft vasculopathy: Practice variations among 50 pediatric heart transplant centers	16
Initial bridge to transplant experience with a bioprosthetic autoregulated artificial heart	16
Cystic fibrosis foundation consensus statements for the care of cystic fibrosis lung transplant recipients	16
Outcomes after heart transplantation and total artificial heart implantation: A multicenter study	16
Pediatric heart transplantation following donation after circulatory death, distant procurement, and ex-situ perfusion	16
Early United States experience with lung donation after circulatory death using thoracoabdominal normothermic regional perfusion	16
Complications of balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension: Impact on the outcome	16
Intravenous iron supplement for iron deficiency in cardiac transplant recipients (IronIC): A randomized clinical trial	16
Two-year outcome of warfarin monotherapy in HeartMate 3 left ventricular assist device: A single-center experience	16
Influence of the donor history of tobacco and marijuana smoking on early and intermediate lung transplant outcomes	16
Impact of thoracotomy approach on right ventricular failure and length of stay in left ventricular assist device implants: an intermacs registry analysis	15
Indications and outcome after lung transplantation in children under 12 years of age: A 16-year single center experience	15
Right ventricular adaptation to pressure-overload: Differences between chronic thromboembolic pulmonary hypertension and idiopathic pulmonary arterial hypertension	15
Effects of cold or warm ischemia and ex-vivo lung perfusion on the release of damage associated molecular patterns and inflammatory cytokines in experimental lung transplantation	15
Endothelin receptor antagonists for pulmonary arterial hypertension and COVID-19: Friend or foe?	15
Risk assessment in pulmonary hypertension based on routinely measured laboratory parameters	15
Ventilation in the prone position improves oxygenation and results in more lungs being transplanted from organ donors with hypoxemia and atelectasis	15
Rotational thromboelastometry reduces blood loss and blood product usage after lung transplantation	15

Age-related differences in hemodynamics and functional status in pulmonary arterial hypertension: Baseline results from the Pulmonary Hypertension Association Registry	15
A clinical and cost-effectiveness analysis of the HeartMate 3 left ventricular assist device for transplant-ineligible patients: A United Kingdom perspective	15
Remote ex vivo lung perfusion at a centralized evaluation facility	15
Biology of myocardial recovery in advanced heart failure with long-term mechanical support	15
Bronchiolitis obliterans syndrome is associated with increased senescent lymphocytes in the small airways	15
Incidence and outcome of post-transplant lymphoproliferative disorders in lung transplant patients: Analysis of ISHLT Registry	15
Donor derived cell free DNA% is elevated with pathogens that are risk factors for acute and chronic lung allograft injury	15
Myocardial edema in COVID-19 on cardiac MRI	15
Predicted heart mass–based size matching among recipients with moderate pulmonary hypertension: Outcomes and sex effect	15
Lung transplantation using allografts with more than 8 hours of ischemic time: A single-institution experience	15
Lactate during ex-situ heart perfusion does not predict the requirement for mechanical circulatory support following donation after circulatory death (DCD) heart transplants	14
Resolution of post-lung transplant ischemia-reperfusion injury is modulated via Resolvin D1-FPR2 and Maresin 1-LGR6 signaling	14
Incremental value of cardiopulmonary exercise testing in intermediate-risk pulmonary arterial hypertension	14
Torque teno virus DNA load as a predictive marker of antibody response to a three-dose regimen of COVID-19 mRNA-based vaccine in lung transplant recipients	14
Pulmonary artery pulsatility index as a predictor of right ventricular failure in left ventricular assist device recipients: A systematic review	14
Improved clinical outcomes associated with the Impella 5.5 compared to the Impella 5.0 in contemporary cardiogenic shock and heart failure patients	14
Development of the Lung Transplant Frailty Scale (LT-FS)	14
Extended post ex-vivo lung perfusion cold preservation predicts primary graft dysfunction and mortality: Results from a multicentric study	14
Heart transplantation outcomes in cardiac sarcoidosis	14
Stroke in pediatric ventricular assist device patients—a pedimacs registry analysis	14
High torque tenovirus (TTV) load before first vaccine dose is associated with poor serological response to COVID-19 vaccination in lung transplant recipients	14
The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Twenty-third pediatric lung transplantation report — 2020; focus on deceased donor	14
ISHLT consensus document on lung transplantation in patients with connective tissue disease: Part I: Epidemiology, assessment of extrapulmonary conditions, candidate evaluation, selection criteria, an	14
Report from the 2018 consensus conference on immunomodulating agents in thoracic transplantation: Access, formulations, generics, therapeutic drug monitoring, and special populations	14
Humoral response to SARS-CoV-2 adenovirus vector vaccination (ChAdOx1 nCoV-19 [AZD1222]) in heart transplant recipients aged 18 to 70 years of age	14
Operating room extubation: A predictive factor for 1-year survival after double-lung transplantation	14
Understanding risk factors and predictors for stroke subtypes in the ENDURANCE trials	14
The impact of pre-implant illness severity on the outcomes of pediatric patients undergoing durable ventricular assist device	13
HLA-DRB1 mismatch-based identification of donor-derived cell free DNA (dd-cfDNA) as a marker of rejection in heart transplant recipients: A single-institution pilot study	13
A simplified strategy for donor-recipient size-matching in lung transplant for interstitial lung disease	13
Innate immunity in lung transplantation	13
Lung transplant outcome following donation after euthanasia	13
International experience using a durable, centrifugal-flow ventricular assist device for biventricular support	13
COVID-19 leading to acute encephalopathy in a patient with heart transplant	13
Donor thyroid hormone therapy and heart transplantation outcomes: ISHLT transplant registry analysis	13
Monitoring of perfusion quality and prediction of donor heart function during ex-vivo machine perfusion by myocardial microcirculation versus surrogate parameters	13
Fourth BNT162b2 vaccination neutralization of omicron infection after heart transplantation	13
Evaluation of 10°C as the optimal storage temperature for aspiration-injured donor lungs in a large animal transplant model	13
Early report from the Pediatric Heart Transplant Society on COVID-19 infections in pediatric heart transplant candidates and recipients	13
Right ventricular area strain from 3-dimensional echocardiography: Mechanistic insight of right ventricular dysfunction in pediatric pulmonary hypertension	13
Higher levels of allograft injury in black patients early after heart transplantation	13
High-intensity interval training in patients with left ventricular assist devices: A pilot randomized controlled trial	13
LVAD decommissioning for myocardial recovery: Long-term ventricular remodeling and adverse events	13
Temporal shift and predictive performance of machine learning for heart transplant outcomes	13
Unmasking right ventricular-arterial uncoupling during fluid challenge in pulmonary hypertension	12
Racial and socioeconomic disparities in pediatric heart transplant outcomes in the era of anti-thymocyte globulin induction	12
Nothing but NETs: Cytokine adsorption correlates with lower circulating nucleosomes and is associated with decreased primary graft dysfunction	12
The Future of heart procurement with donation after circulatory death: Current practice and opportunities for advancement	12
First Results of Soprano: Macitentan in Patients (pts) with Pulmonary Hypertension (PH) Post-Left Ventricular Assist Device (LVAD) Implantation	12
Ventilation parameters and early graft function in double lung transplantation	12
Mitochondrial transplant after ischemia reperfusion promotes cellular salvage and improves lung function during ex-vivo lung perfusion	12
Right single lung transplantation or double lung transplantation compared with left single lung transplantation in chronic obstructive pulmonary disease	12
Sex disparities in the current era of pediatric heart transplantation in the United States	12
Proteomic profiling identifies CLEC4C expression as a novel biomarker of primary graft dysfunction after heart transplantation	12
Interplay of sex hormones and long-term right ventricular adaptation in a Dutch PAH-cohort	12
Patient and disease characteristics of the first 500 patients with pulmonary arterial hypertension treated with selexipag in real-world settings from SPHERE	12
Incorporation of renal function in mortality risk assessment for pulmonary arterial hypertension	12
Temporary mechanical circulatory support: Devices, outcomes, and future directions	12
Putting ethics and clinical decision making before politics: requiring COVID-19 immunization for Solid Organ Transplantation (SOT) Candidates and their Support Team	12
The modified US heart allocation system improves transplant rates and decreases status upgrade utilization for patients with hypertrophic cardiomyopathy	12
Safety of reduced anti-thrombotic strategy in patients with HeartMate 3 left ventricular assist device	12
Circulating microRNAs in cellular and antibody-mediated heart transplant rejection	12
WITHDRAWN: Executive Summary - The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients	12
Inflammatory responses in lungs from donation after brain death: Mechanisms and potential therapeutic targets	12
Machine-learning–based exploration to identify remodeling patterns associated with death or heart-transplant in pediatric-dilated cardiomyopathy	12
Preventing alloimmune rejection using circular RNA FSCN1-silenced dendritic cells in heart transplantation	12
Immunologic risk stratification of pediatric heart transplant patients by combining HLAMatchmaker and PIRCHE-II	12
Whole transcriptome profiling of prospective endomyocardial biopsies reveals prognostic and diagnostic signatures of cardiac allograft rejection	12
The heart–gut microbiome axis in advanced heart failure	12
Comparison of de novo donor-specific antibodies between living and cadaveric lung transplantation	11
COMPETENCE Trial: The EVAHEART 2 continuous flow left ventricular assist device	11
A national pilot of donation after circulatory death (DCD) heart transplantation within the United Kingdom	11
Lung transplantation disparities based on diagnosis for patients bridging to transplant on extracorporeal membrane oxygenation	11
Heart retransplantation following COVID-19 illness in a heart transplant recipient	11
First 5-year multicentric clinical trial experience with the HeartMate 3 left ventricular assist system	11
Bridging to transplant with HeartMate 3 left ventricular assist devices in the new heart organ allocation system: An individualized approach	11
Outcomes of bariatric surgery in patients with left ventricular assist device	11
Temporal trends in the use and outcomes of temporary mechanical circulatory support as a bridge to cardiac transplantation in Spain. Final report of the ASIS-TC study	11
Impact of cytomegalovirus infection on gene expression profile in heart transplant recipients	11
Plasma kallikrein predicts primary graft dysfunction after heart transplant	11
Prognostic value of improvement endpoints in pulmonary arterial hypertension trials: A COMPERA analysis	11
Gastrointestinal angiodysplasia in heart failure and during CF LVAD support	11
Bacteriophage therapy as a treatment option for complex cardiovascular implant infection: The German Heart Center Berlin experience	11
Idiopathic pulmonary arterial hypertension patients with a high H2FPEF-score: Insights from the Amsterdam UMC PAH-cohort	11
Machine learning, artificial intelligence and mechanical circulatory support: A primer for clinicians	11
Factors contributing to exercise capacity in chronic thromboembolic pulmonary hypertension with near-normal hemodynamics	11
Full recovery of right ventricular systolic function in children undergoing bilateral lung transplantation for severe PAH	11
Cardiac allograft vasculopathy and secondary outcomes of hepatitis C-positive donor hearts at 1 year after transplantation	11
The introduction of a super-urgent heart allocation scheme in the UK: A 2-year review	11
Hemodynamic reserve predicts early right heart failure after LVAD implantation	10
Impact of incorporating long-term survival for calculating transplant benefit in the US lung transplant allocation system	10
Effect of riociguat on right ventricular function in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension	10
Patient factors associated with left ventricular assist device infections: A scoping review	10
Determining the impact of ex-vivo lung perfusion on hospital costs for lung transplantation: A retrospective cohort study	10
Residual mitral regurgitation in patients with left ventricular assist device support – An INTERMACS analysis	10